Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis
- PMID: 10694562
- DOI: 10.1200/JCO.2000.18.5.1094
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis
Abstract
Purpose: The optimum management of hepatocellular carcinoma (HCC) associated with cirrhosis has not yet been clarified. Very few data are available in the literature regarding the prognosis after resection of HCC associated with hepatitis B virus (HBV)-related cirrhosis. This study evaluated the long-term results and prognostic factors after resection of HCC complicating HBV-related cirrhosis.
Patients and methods: One hundred forty-six patients with HBV-related Child's A or B cirrhosis who had undergone resection of HCC over a 10-year period were prospectively studied for long-term results. They were compared with 155 noncirrhotic patients with HBV-related HCC resected in the same period.
Results: The overall survival results of cirrhotic patients after resection of HCC were comparable to those of noncirrhotic patients (5-year survival, 44.3% v 45.6%, respectively; P =.216), but the former group had significantly smaller tumors. Stratified according to tumor size, the survival results were similar between cirrhotic and noncirrhotic patients with tumors </= 5 cm (5-year survival, 60.7% v 61.7%, respectively; P =.327) but were worse in cirrhotic compared with noncirrhotic patients with tumors greater than 5 cm (5-year survival, 27.8% v 39.5%, respectively; P =.034). Stage by stage, there were no significant differences in survival results between cirrhotic and noncirrhotic patients. Preoperative serum AST level greater than 100 IU/L (P =.004), perioperative transfusion (P =.015), and venous invasion (P <.001) were independent adverse prognostic factors.
Conclusion: The prognosis after resection of HCCs less than 5 cm in patients with compensated HBV-related cirrhosis was comparable to that of noncirrhotic patients, which suggests that surgical resection may be considered a first-line treatment for these patients. Patients with underlying active hepatitis as indicated by a high preoperative transaminase level are less favorable candidates for resection. Further studies are needed to define the relative roles of resection and transplantation for HCC associated with hepatitis B cirrhosis.
Similar articles
-
Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.Ann Surg Oncol. 2014 Jul;21(7):2406-12. doi: 10.1245/s10434-014-3505-0. Epub 2014 Feb 28. Ann Surg Oncol. 2014. PMID: 24577811
-
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917. Ann Surg. 2014. PMID: 25203882
-
Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.Ann Surg Oncol. 2014 Feb;21(2):458-65. doi: 10.1245/s10434-013-3302-1. Epub 2013 Oct 17. Ann Surg Oncol. 2014. PMID: 24132624
-
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178. J Surg Oncol. 2002. PMID: 12451624 Review.
-
Hepatocellular cancer: resection or transplantation.J Hepatobiliary Pancreat Surg. 1998;5(1):18-23. doi: 10.1007/pl00009945. J Hepatobiliary Pancreat Surg. 1998. PMID: 9683749 Review.
Cited by
-
RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.Oncotarget. 2015 Feb 20;6(5):3432-42. doi: 10.18632/oncotarget.3092. Oncotarget. 2015. PMID: 25605019 Free PMC article.
-
The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma.Int J Hepatol. 2011;2011:416459. doi: 10.4061/2011/416459. Epub 2011 May 30. Int J Hepatol. 2011. PMID: 21994855 Free PMC article.
-
Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.Cancer Causes Control. 2021 Apr;32(4):317-325. doi: 10.1007/s10552-020-01386-x. Epub 2021 Jan 4. Cancer Causes Control. 2021. PMID: 33394207
-
Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma.Int J Mol Sci. 2016 Jun 9;17(6):911. doi: 10.3390/ijms17060911. Int J Mol Sci. 2016. PMID: 27294917 Free PMC article.
-
The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.Front Cell Infect Microbiol. 2022 Feb 8;12:725642. doi: 10.3389/fcimb.2022.725642. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35211422 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical